Aug 15 (Reuters) - European shares came off multi-month highs on Friday, as declines in heavyweight tech and financial shares offset gains from some corporate earnings, while investors monitored a crucial U.S.-Russia summit.
The pan-European STOXX 600 index (.STOXX), closed 0.1% lower, after hitting a near five-month high earlier in the session.
Investor focus was on a meeting between U.S. President Donald Trump and his Russian counterpart Vladimir Putin in Alaska later in the day that investors hope could pave the way for a resolution of the Ukraine conflict.
Trump said he would not negotiate on behalf of Ukraine and would let Kyiv decide whether to engage in territorial swaps with Russia.
Analysts at Jefferies said that any progress towards de-escalation could benefit consumer, construction, materials and growth-oriented sectors, which have been relatively underinvested in Europe.
Aerospace and defence (.SXPARO), stocks fell 0.8% ahead of the summit.
Steve Sosnick, chief market analyst at Interactive Brokers, said: "Barring something truly outrageous - positive or negative - markets are not necessarily treating it (U.S.-Russia summit) as important from a market point of view."
Technology stocks fell 0.6%, weighing on the STOXX 600 index.
ASML (ASML.AS), the world's biggest supplier of computer chip-making equipment, fell 1% after U.S. peer Applied Materials (AMAT.O), lowered its fourth-quarter earnings forecast due to weak demand in China and impacts from tariff uncertainty.
The Dutch firm had issued a similar warning in mid-July, saying it might not achieve its 2026 growth forecast. Chip stocks BE Semiconductor (BESI.AS), and ASMI (ASMI.AS), dropped 3.3% and 2.8%, respectively.
MINERS UP, HEALTHCARE RECOVERING
On the flip side, miners (.SXPP), were the top gainers, adding 0.8%. Antofagasta (ANTO.L), rose 1.2% after a jump in half-year core earnings on Thursday, helping peers, including Anglo American (AAL.L).
Healthcare shares (.SXDP), opens new tab, which have taken a beating this year from uncertainty around Trump's pharma tariffs, were on track for a recovery.
The healthcare index logged its seventh consecutive session of gains, its longest streak since late January.
Regional bourses were mixed, with Germany’s DAX (.GDAXI), and the UK’s FTSE (.FTSE), declining, while France’s CAC (.FCHI), and Spain’s IBEX (.IBEX), posted gains.
The STOXX 600 also logged a second weekly gain, driven by expectations of a U.S. rate cut in September and strong corporate earnings.
Pandora (PNDORA.CO), bottomed the STOXX 600, falling 18.4%, after the Danish jewellery maker flagged weakening sales in its key European markets.
This was its steepest one-day fall in seven years.
Standard Chartered (STAN.L), fell 7.2% after a U.S. Republican lawmaker called for probe against the bank over alleged "ongoing sanctions evasion".
NKT (NKT.CO), jumped 8.6% to top the STOXX 600, logging its best day since May 2022, after the Danish power cable solutions provider raised its outlook for 2025.
Reporting by Twesha Dikshit, Sruthi Shankar, Sukriti Gupta and Purvi Agarwal in Bengaluru; Editing by Rashmi Aich, Eileen Soreng and Clelia Oziel
